Last reviewed · How we verify
ethinylestradiol and drospirenone — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
ethinylestradiol and drospirenone (ethinylestradiol and drospirenone) — Adana Numune Training and Research Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ethinylestradiol and drospirenone TARGET | ethinylestradiol and drospirenone | Adana Numune Training and Research Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ethinylestradiol and drospirenone CI watch — RSS
- ethinylestradiol and drospirenone CI watch — Atom
- ethinylestradiol and drospirenone CI watch — JSON
- ethinylestradiol and drospirenone alone — RSS
Cite this brief
Drug Landscape (2026). ethinylestradiol and drospirenone — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinylestradiol-and-drospirenone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab